[1] |
WANG Zhaobu, LI Xing, YU Xinmiao, JIN Feng.
Important research progress in clinical practice for early breast cancer in 2023
[J]. China Oncology, 2024, 34(2): 151-160.
|
[2] |
LIU Qi, CHANG Cai, LI Jiawei.
Research progress on the correlation between imaging features and the molecular subtype, histopathology, clinical prognosis of ductal carcinoma in situ of the breast
[J]. China Oncology, 2024, 34(2): 201-209.
|
[3] |
LIU Jia, LI Guanghan, GAO Luying, ZHANG Zijie, WANG Ying, XIONG Ying, ZHANG Bo.
Establishment and test of graded diagnostic model of thyroid cancer in children and adolescents
[J]. China Oncology, 2022, 32(5): 397-403.
|
[4] |
QI Mengfang, TIAN Tian, HUANG Rui.
Clinicopathological characteristics and 131I treatment of differentiated thyroid carcinoma in children and adolescents of different age groups
[J]. China Oncology, 2022, 32(5): 404-409.
|
[5] |
Expert Committee of Nuclear Medicine, Chinese society of Clinical Oncology, Expert Committee of Thyroid Cancer, Chinese society of Clinical Oncology, Committee of Thyroid Disease Society, China International Exchange and Promotive Association for Medical and Health Care, Committee of Thyroid Disease Prevention and Treatment Society, China Population Culture Promotion Association.
Expert consensus on management of differentiated thyroid carcinoma in children and adolescents (2022 edition)
[J]. China Oncology, 2022, 32(5): 451-468.
|
[6] |
Onco-endocrinology Society of Chinese Anti-Cancer Association, Onco-endocrinology Committee of Chongqing Association of Integrative Medicine.
Guidelines for the management of tumor-associated hyperglycemia (2021 edition)
[J]. China Oncology, 2021, 31(7): 651-688.
|
[7] |
WU Qinan , TONG Nanwei .
Interpretation of Guidelines for the Management of Tumor-associated Hyperglycemia (2021 edition)
[J]. China Oncology, 2021, 31(12): 1153-1161.
|
[8] |
MA Jiaojiao, ZHANG Bo.
The advantages and disadvantages of ultrasound risk stratification of thyroid nodules
[J]. China Oncology, 2020, 30(7): 546-550.
|
[9] |
CHEN Wanling, MA Yuhui , ZHANG Xiangwu, HUANG Qiubo, ZHAO Guangqiang , LEI Yujie, PENG Wei, YIN Xin, YANG Yanfen, TAN Hui, ZHANG Lei, HUANG Yunchao.
Combination of LungPro Virtual Bronchoscopy Navigation System with cytological rapid on-site evaluation with and without radial endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions
[J]. China Oncology, 2020, 30(2): 135-141.
|
[10] |
YU Mei,MEI Qi,HAN Yingying,ZHAI Lingyun,SHA Hongfang,XU Xiangyong,NI Juan,CUI Jianwei,DING Hong .
Value of contrast-enhanced ultrasound in monitoring liver cirrhotic and dysplastic nodules and early diagnosis of hepatocellular carcinomas
[J]. China Oncology, 2019, 29(9): 709-714.
|
[11] |
YANG Ke, ZHENG Rong, LIN Yansong.
The interpretation of management guidelines for children with thyroid nodules and differentiated thyroid cancer: radioactive iodine therapy and new progress
[J]. China Oncology, 2019, 29(6): 401-411.
|
[12] |
GAO Luying, LIN Yansong, JIANG Yuxin, LI Jianchu, LI Hui, ZHANG Bo, LIU Ruyu, XI Xuehua, GAO Qiong, WANG Ying, ZHAO Ruina.
Evaluation of short-term efficacy of apatinib using cervical ultrasound and thyroglobulin in the treatment of progressive radioactive iodine-refractory differentiated thyroid cancer
[J]. China Oncology, 2019, 29(6): 418-422.
|
[13] |
SUI Huimin, LIU Jierui, WANG Tong, ZHU Zhaohui, LIN Yansong.
Clinicopathological risk factors for distant metastasis of differentiated thyroid carcinoma in children and adolescents
[J]. China Oncology, 2019, 29(6): 423-428.
|
[14] |
LU Chenghui, LI Jiao, LIU Xinfeng, WANG Guoqiang, WANG Zenghua, WANG Xufu.
Clinical outcome after 131I treatment in differentiated thyroid cancer with negative stimulated thyroglobulin and lymph node metastasis
[J]. China Oncology, 2019, 29(6): 429-433.
|
[15] |
LIU Jierui, LIANG Jun, LIN Yansong.
Relationship between preablative stimulated thyroglobulin and the excellent response in differentiated thyroid carcinoma
[J]. China Oncology, 2019, 29(2): 125-130.
|